Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

38.23
+0.20000.53%
Post-market: 38.250.0205+0.05%19:54 EDT
Volume:4.74M
Turnover:180.15M
Market Cap:77.24B
PE:19.44
High:38.32
Open:37.93
Low:37.77
Close:38.03
Loading ...

Europe's Pharma Stocks Look Cheap but Tariffs Cloud the Outlook -- Barrons.com

Dow Jones
·
8 hours ago

GSK announces approval of myeloma treatment Blenrep in EU

TIPRANKS
·
11 hours ago

GSK Rallies Thursday, Outperforms Market

Dow Jones
·
11 hours ago

GSK Advances in NASH Treatment with Promising Phase 2a Study

TIPRANKS
·
23 Jul

GSK Expands Share Buyback Program with Recent Purchase

TIPRANKS
·
22 Jul

J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
22 Jul

GSK price target lowered to 1,290 GBp from 1,355 GBp at Morgan Stanley

TIPRANKS
·
19 Jul

Shore Capital Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
19 Jul

GSK’s Linerixibat Study: A Potential Game-Changer for PBC Treatment

TIPRANKS
·
19 Jul

GSK Falls Friday, Underperforms Market

Dow Jones
·
19 Jul

GSK Executives Acquire ADSs Following Dividend Reinvestment

TIPRANKS
·
18 Jul

Stocks to Watch Friday: Netflix, Norfolk Southern, Amex -- WSJ

Dow Jones
·
18 Jul

Berenberg Bank Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
18 Jul

GSK provides update on US FDA advisory committee review of Blenrep

TIPRANKS
·
18 Jul

GSK’s Shingrix Vaccine Gains FDA Approval for Prefilled Syringe

TIPRANKS
·
17 Jul

GSK Continues Share Buyback with Recent Purchase

TIPRANKS
·
17 Jul

Barclays Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
16 Jul

GSK Slides Tuesday, Underperforms Market

Dow Jones
·
16 Jul

GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab

TIPRANKS
·
16 Jul

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
15 Jul